Free Trial

Johnson & Johnson (JNJ) SEC Filings & 10K Form

Johnson & Johnson logo
$154.60 -0.40 (-0.26%)
Closing price 05/6/2025 03:59 PM Eastern
Extended Trading
$154.80 +0.20 (+0.13%)
As of 04:57 AM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Recent Johnson & Johnson SEC Filings

DateFilerForm TypeView
04/28/2025
4:48 PM
Johnson & Johnson (Issuer)
Joly Hubert (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/28/2025
4:50 PM
Johnson & Johnson (Issuer)
McClellan Mark B. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/28/2025
4:52 PM
Johnson & Johnson (Issuer)
WEINBERGER MARK A (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/28/2025
4:54 PM
Johnson & Johnson (Issuer)
West Nadja (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/28/2025
4:57 PM
Johnson & Johnson (Issuer)
Woods Eugene A. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/28/2025
4:38 PM
Doudna Jennifer A (Reporting)
Johnson & Johnson (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
04/28/2025
4:39 PM
Beckerle Mary C (Reporting)
Johnson & Johnson (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
04/28/2025
4:41 PM
HEWSON MARILLYN A (Reporting)
Johnson & Johnson (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
04/28/2025
4:45 PM
Johnson & Johnson (Issuer)
Johnson Paula A (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/23/2025
3:04 PM
Johnson & Johnson (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
04/23/2025
12:41 PM
Bowyer Research, Inc. (Filed by)
Johnson & Johnson (Subject)
Form PX14A6G
04/15/2025
7:14 AM
Johnson & Johnson (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/03/2025
3:43 PM
Johnson & Johnson (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/20/2025
1:00 PM
Johnson & Johnson (Subject)
Mercy Investment Services, Inc. (Filed by)
Form PX14A6G
03/19/2025
7:07 PM
Duato Joaquin (Reporting)
Johnson & Johnson (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/12/2025
5:44 AM
Johnson & Johnson (Filer)
Form ARS
03/12/2025
5:48 AM
Johnson & Johnson (Filer)
Form DEFA14A
03/12/2025
5:40 AM
Johnson & Johnson (Filer)
Form DEF 14A
03/07/2025
4:01 PM
Intra-Cellular Therapies, Inc. (Subject)
Johnson & Johnson (Filed by)
Form DFAN14A
03/06/2025
3:42 PM
HEWSON MARILLYN A (Reporting)
Johnson & Johnson (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/28/2025
6:05 PM
Johnson & Johnson (Issuer)
Woods Eugene A. (Reporting)
Form 5
Annual statement of changes in beneficial ownership of securities  
02/28/2025
10:43 AM
Johnson & Johnson (Filer)
Form CERT
02/26/2025
5:42 PM
Decker Robert J (Reporting)
Johnson & Johnson (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/26/2025
4:22 PM
Johnson & Johnson (Filer)
Form 8-A12B
02/26/2025
3:23 PM
Johnson & Johnson (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/25/2025
4:21 PM
Intra-Cellular Therapies, Inc. (Subject)
Johnson & Johnson (Filed by)
Form DFAN14A
02/25/2025
2:05 PM
Decker Robert J (Reporting)
Johnson & Johnson (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
02/21/2025
3:28 PM
Johnson & Johnson (Filer)
Form 424B2
Transaction specifc information for a delayed shelf offering
02/20/2025
4:26 PM
Johnson & Johnson (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/19/2025
4:37 PM
Johnson & Johnson (Issuer)
Wengel Kathryn E (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/19/2025
4:44 PM
Johnson & Johnson (Issuer)
Wolk Joseph J (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/19/2025
4:25 PM
Forminard Elizabeth (Reporting)
Johnson & Johnson (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/19/2025
4:27 PM
Johnson & Johnson (Issuer)
Mulholland Kristen (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/19/2025
4:29 PM
Johnson & Johnson (Issuer)
REED JOHN C (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/19/2025
4:31 PM
Johnson & Johnson (Issuer)
Schmid Timothy (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/19/2025
4:33 PM
Johnson & Johnson (Issuer)
Swanson James D. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/19/2025
4:35 PM
Johnson & Johnson (Issuer)
Taubert Jennifer L (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/19/2025
4:16 PM
Broadhurst Vanessa (Reporting)
Johnson & Johnson (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/19/2025
4:18 PM
Duato Joaquin (Reporting)
Johnson & Johnson (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/19/2025
4:22 PM
Decker Robert J (Reporting)
Johnson & Johnson (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/19/2025
4:07 PM
Johnson & Johnson (Subject)
Form FWP
URGENT: This Altcoin Opportunity Won’t Wait – Act Now (Ad)

My friends Joel and Adam have a simple motto: "For us, it's always a bull market." That’s because their 92% win rate trading system is built to profit in any market – whether Bitcoin is mooning, correcting, or chopping sideways. No more guessing. No more stress. Just precision trades that put you in control.

>> See How In Their FREE Workshop
02/19/2025
4:11 PM
Johnson & Johnson (Filer)
Form 424B2
Transaction specifc information for a delayed shelf offering
02/19/2025
5:04 AM
Johnson & Johnson (Filer)
Form 424B5
02/18/2025
8:46 PM
Johnson & Johnson (Issuer)
Schmid Timothy (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/18/2025
8:33 PM
Johnson & Johnson (Issuer)
Schmid Timothy (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/18/2025
8:13 PM
Johnson & Johnson (Issuer)
Wolk Joseph J (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/18/2025
8:16 PM
Johnson & Johnson (Issuer)
Wengel Kathryn E (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/18/2025
8:01 PM
Decker Robert J (Reporting)
Johnson & Johnson (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/18/2025
8:02 PM
Duato Joaquin (Reporting)
Johnson & Johnson (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/18/2025
8:03 PM
Forminard Elizabeth (Reporting)
Johnson & Johnson (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/18/2025
8:05 PM
Johnson & Johnson (Issuer)
Mulholland Kristen (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/18/2025
8:06 PM
Johnson & Johnson (Issuer)
Swanson James D. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/18/2025
8:08 PM
Johnson & Johnson (Issuer)
Taubert Jennifer L (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/18/2025
8:11 PM
Johnson & Johnson (Issuer)
REED JOHN C (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/18/2025
7:58 PM
Broadhurst Vanessa (Reporting)
Johnson & Johnson (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/18/2025
7:09 AM
Johnson & Johnson (Filer)
Form 424B5
02/13/2025
2:10 PM
Johnson & Johnson (Filer)
Form 13F-HR
Initial Quarterly Form 13F Holdings report filed by institutional managers
02/12/2025
5:32 PM
Johnson & Johnson (Issuer)
Wengel Kathryn E (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/12/2025
5:35 PM
Johnson & Johnson (Issuer)
Wolk Joseph J (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/12/2025
5:37 PM
Forminard Elizabeth (Reporting)
Johnson & Johnson (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/12/2025
5:38 PM
Decker Robert J (Reporting)
Johnson & Johnson (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/12/2025
5:10 PM
Johnson & Johnson (Issuer)
Schmid Timothy (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/12/2025
5:18 PM
Johnson & Johnson (Issuer)
Taubert Jennifer L (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/12/2025
5:21 PM
Johnson & Johnson (Issuer)
Mulholland Kristen (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/12/2025
4:53 PM
Duato Joaquin (Reporting)
Johnson & Johnson (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/12/2025
5:07 PM
Johnson & Johnson (Issuer)
Swanson James D. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/12/2025
4:38 PM
Broadhurst Vanessa (Reporting)
Johnson & Johnson (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/11/2025
6:40 PM
Johnson & Johnson (Issuer)
Wolk Joseph J (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/11/2025
6:41 PM
Johnson & Johnson (Issuer)
Taubert Jennifer L (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/11/2025
6:42 PM
Johnson & Johnson (Issuer)
Wengel Kathryn E (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/11/2025
6:43 PM
Duato Joaquin (Reporting)
Johnson & Johnson (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/07/2025
12:27 PM
Johnson & Johnson (Subject)
Wolk Joseph J (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
01/22/2025
4:25 PM
Intra-Cellular Therapies, Inc. (Subject)
Johnson & Johnson (Filed by)
Form DFAN14A
01/22/2025
3:55 PM
Johnson & Johnson (Filer)
Form 8-K/A
01/22/2025
5:35 AM
Johnson & Johnson (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/13/2025
4:27 PM
Intra-Cellular Therapies, Inc. (Subject)
Johnson & Johnson (Filed by)
Form DFAN14A
12/12/2024
4:16 PM
Johnson & Johnson (Issuer)
Woods Eugene A. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/12/2024
4:27 PM
Johnson & Johnson (Issuer)
WEINBERGER MARK A (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/12/2024
4:09 PM
HEWSON MARILLYN A (Reporting)
Johnson & Johnson (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
12/04/2024
12:25 PM
Hait William (Reporting)
Johnson & Johnson (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
11/06/2024
8:23 AM
Johnson & Johnson (Subject)
NEW YORK STOCK EXCHANGE LLC (Filed by)
Form 25-NSE
11/01/2024
10:05 AM
CVRx, Inc. (Subject)
Johnson & Johnson (Filed by)
Form SC 13G/A
10/31/2024
4:57 PM
Johnson & Johnson (Issuer)
REED JOHN C (Reporting)
Form 4/A
10/23/2024
3:02 PM
Johnson & Johnson (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
10/21/2024
5:18 PM
Johnson & Johnson (Issuer)
Wolk Joseph J (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
10/18/2024
4:23 PM
Johnson & Johnson (Filed by)
Rapport Therapeutics, Inc. (Subject)
Form SC 13G
10/18/2024
3:47 PM
Johnson & Johnson (Filed by)
MeiraGTx Holdings plc (Subject)
Form SC 13G/A
10/15/2024
3:39 PM
DAVIS D SCOTT (Reporting)
Johnson & Johnson (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
10/15/2024
6:37 AM
Johnson & Johnson (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/09/2024
4:07 PM
Johnson & Johnson (Issuer)
Mulholland Kristen (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
09/20/2024
3:19 PM
Johnson & Johnson (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
URGENT: This Altcoin Opportunity Won’t Wait – Act Now (Ad)

My friends Joel and Adam have a simple motto: "For us, it's always a bull market." That’s because their 92% win rate trading system is built to profit in any market – whether Bitcoin is mooning, correcting, or chopping sideways. No more guessing. No more stress. Just precision trades that put you in control.

>> See How In Their FREE Workshop
09/12/2024
3:43 PM
HEWSON MARILLYN A (Reporting)
Johnson & Johnson (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
09/12/2024
3:44 PM
Johnson & Johnson (Issuer)
Woods Eugene A. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
09/10/2024
3:26 PM
Johnson & Johnson (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/03/2024
3:48 PM
Decker Robert J (Reporting)
Johnson & Johnson (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
08/29/2024
1:05 PM
Johnson & Johnson (Filer)
Form N-PX
Annual Report of Proxy Voting Record of Registered Management Investment Company  
08/26/2024
3:26 PM
Johnson & Johnson (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/09/2024
3:35 PM
Johnson & Johnson (Filer)
Form 13F-HR
Initial Quarterly Form 13F Holdings report filed by institutional managers
07/30/2024
8:06 PM
Johnson & Johnson (Filed by)
Rallybio Corp (Subject)
Form SC 13G
07/25/2024
3:02 PM
Johnson & Johnson (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
(Data available from 1/1/2016 forward)


Related Companies and Tools


This page (NYSE:JNJ) was last updated on 5/7/2025 by MarketBeat.com Staff
From Our Partners